Puma Biotechnology, Inc. , a biopharmaceutical company, announced that clinical data on neratinib will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025. The AACR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback